THESYLVESTERDIFFERENCE
2021 ACCOMPLISHMENTS REPORT
As I reflect on 2021, I am humbled by Sylvester’s impact on our community. The COVID-19 pandemic continued to shape us, but our resilience and adaptability allowed us to pursue our mission, conduct innovative science, and provide world-renowned cancer care.
DRIVING PATIENT-FOCUSED RESEARCH
Sylvester Investigator’s Hodgkin Lymphoma Protocol Could Change Care for Relapsed, Refractory Patients. The results of a Phase 2 study looking at treating relapsed or refractory Hodgkin lymphoma with a new drug protocol were outstanding. They even surprised one of the world’s leading lymphoma experts, Craig Moskowitz, M.D., physician in chief of the Oncology Service Line at Sylvester Comprehensive Cancer Center.
Read Full Story